Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Brightcove Inc (BCOV)?

Page 1 of 2

Hedge funds are not perfect. They have their bad picks just like everyone else. Micron, a stock hedge funds have loved, lost 50% during the last 12 months ending on October 30. Although hedge funds are not perfect, their consensus picks do deliver solid returns, however. Our data show the top 30 S&P 500 stocks among hedge funds at the end of September 2014 yielded an average return of 9.5% in the same time period, vs. a gain of 5.2% for the S&P 500 Index. Because hedge funds have a lot of resources, and their consensus picks do well, we pay attention to what they think. In this article, we analyze what the elite funds think of Brightcove Inc (NASDAQ:BCOV).

Brightcove Inc (NASDAQ:BCOV) shareholders have witnessed a decrease in hedge fund interest recently. At the end of this article, we will also compare BCOV to other stocks including Richmont Mines Inc. (USA) (NYSEAMEX:RIC), Biotie Therapies Oyj (ADR) (NASDAQ:BITI), and New York & Company, Inc. (NYSE:NWY) to get a better sense of its popularity.

Follow Brightcove Inc (NASDAQ:BCOV)
Trade (NASDAQ:BCOV) Now!

In the financial world there are a large number of indicators market participants put to use to evaluate publicly traded companies. A pair of the most useful indicators is composed of hedge fund and insider trading indicators. Our researchers have shown that, historically, those who follow the best picks of the elite investment managers can outpace their index-focused peers by a very impressive margin (see the details here).

Keeping this in mind, let’s review the new action surrounding Brightcove Inc (NASDAQ:BCOV).

Hedge fund activity in Brightcove Inc (NASDAQ:BCOV)

At the end of the third quarter, a total of 14 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -7% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were upping their stakes considerably (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Wilmot B. Harkey and Daniel Mack’s Nantahala Capital Management has the number one position in Brightcove Inc (NASDAQ:BCOV), worth close to $4.9 million, corresponding to 0.7% of its total 13F portfolio. Sitting at the No. 2 spot is Jim Simons of Renaissance Technologies, with a $1.8 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Remaining professional money managers with similar optimism contain Tom Henwood’s OMT Capital Management, Israel Englander’s Millennium Management and D. E. Shaw’s D E Shaw.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!